Home / Share Price Target / Pfizer
Pfizer Share Price Target 2024, 2025, 2026 to 2039 With Charts
Pfizer Limited | |||
 | Symbol: PFIZER | ||
| Price: ₹5,131.29 | |||
| Exchange: NSE | |||
| Healthcare -> Drug Manufacturers - General | |||
Show Table of Contents
Table of Contents
- 1: Pfizer Brief Company Overview
- 1.1: Pfizer Limited: A Global Pharmaceutical Leader
- 1.1.1: Key Products and Services
- 1.1.2: Reputation in the Industry
- 1.1.3: Commitment to Patients
- 1.2: Pfizer Financial Performance
- 1.2.1: Is Pfizer A Good Buy For Long Term?
- 2: Approach 1: Technical Analysis Paired With Price Action
- 2.1: Pfizer Share Price Target For 2024
- 2.1.1: Pfizer Share Price Target Table For 2024
- 2.1.2: Summary: Pfizer Share Price Prediction For 2024
- 2.2: Pfizer Share Price Target For 2025
- 2.2.1: Pfizer Share Price Target Table For 2025
- 2.2.2: Summary: Pfizer Share Price Prediction For 2025
- 3: Approach 2: Machine Learning By Studying Historical Prices
- 3.1: Pfizer Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
- 3.2: Pfizer Share Price Target Table From 2024, 2025, 2026 to 2039
- 4: Pfizer Past Performance
Pfizer Brief Company Overview
Pfizer Limited: A Global Pharmaceutical Leader
Pfizer Limited is a leading pharmaceutical company in India with a global presence. Established in 1950, it manufactures and markets a diverse range of products across various therapeutic areas.
Key Products and Services
- Neuro/Central Nervous System
- Cardiovascular
- Oncology
- Vaccines
- Vitamins/Minerals/Nutrients
Reputation in the Industry
Pfizer Limited has built a strong reputation in the pharmaceutical industry for its high-quality products and commitment to innovation.Commitment to Patients
The company is dedicated to providing access to affordable, effective treatments that improve the lives of patients worldwide.Pfizer Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 20,131.5 Crore | Market valuation of Pfizer's shares. |
| Revenue (TTM) | 2,219.18 Crore | Total revenue generated by Pfizer over the past twelve months. |
| Net Income (TTM) | +502.11 Crore | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | 25% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | 22.62% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) | -13.2% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) | -13.7% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio | 3.54 | Company's total debt divided by total shareholder equity. |
| Total Debt | 115.98 Crore | Sum of Pfizer's current & long-term financial obligations. |
| Total Cash | 1,892.15 Crore | Total amount of liquid funds available to Pfizer. |
| Beta | 0.31 | Beta is less than 1 indicating that the Pfizer's price is less volatile than the market. |
Is Pfizer A Good Buy For Long Term?
Pfizer's strong financial performance makes it a compelling long-term investment. Its solid revenue and profit growth indicate a healthy business. The company's manageable debt and strong cash balance further support its financial stability. Despite recent revenue decline, its consistent earnings growth, impressive profit margin, and strong returns over various time frames demonstrate its long-term potential. Overall, Pfizer is a promising stock for investors seeking a well-established and financially sound company with a proven track record of growth.
To predict the Pfizer's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Pfizer Share Price Target For 2024
The line chart displays the monthly closing prices of Pfizer with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Pfizer shares in 2024, see the table below.
Pfizer Share Price Target Table For 2024
| Pfizer's Levels | Value | Reason/Importance |
|---|---|---|
| 2024 Target 3 | 5265.29 (+2.61%) | Fibonacci Extension Level 150% |
| 2024 Target 2 | 5209.00 (+1.51%) | Price Action: 04 Nov 2024 High |
| 2024 Target 1 | 5153.64 (+0.43%) | Price Action: Oct 2024 High |
| Current Price | 5131.29 | Pfizer's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 5120.00 (-0.23%) | Price Action: Jun 2021 Low |
| Stop Loss 2 | 5057.63 (-1.44%) | Fibonacci Retracement Extended 40% |
| Stop Loss 3 | 5000.00 (-2.56%) | Price Action: Mar 2024 High |
Summary: Pfizer Share Price Prediction For 2024
In summary, Pfizer has surged by ₹862.34, achieving a notable +20.20% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Pfizer for 2024 predicts an additional rise of 0.43% to 2.61% by the end of 2024 with three potential targets T1: 5153.64, T2: 5209.00, T3: 5265.29. Stop Loss at SL1: 5120.00, SL2: 5057.63, SL3: 5000.00.
Pfizer has a 52-week high of ₹6451.14, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹3950.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's share price prediction, let's now check what 2025 might hold for Pfizer.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Pfizer Share Price Target For 2025
The line chart displays the monthly closing prices of Pfizer with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Pfizer shares in 2025, see the table below.
Pfizer Share Price Target Table For 2025
| Pfizer's Levels | Value | Reason/Importance |
|---|---|---|
| 2025 Target 3 | 6783.95 (+32.2%) | Price Action: Chart |
| 2025 Target 2 | 6657.46 (+29.74%) | Price Action: Chart |
| 2025 Target 1 | 6591.54 (+28.45%) | Custom Fibonacci Extension Lvl 64.9% |
| Current Price | 5131.29 | Pfizer's 1 share price as of Thu 21 Nov 2024 |
| Stop Loss 1 | 4785.05 (-6.75%) | Price Action: Dec 2021 Low |
| Stop Loss 2 | 4673.85 (-8.92%) | Price Action: Feb 2021 High |
| Stop Loss 3 | 4625.00 (-9.87%) | Price Action: Nov 2022 High |
Summary: Pfizer Share Price Prediction For 2025
In summary, Pfizer has surged by ₹862.34, achieving a notable +20.20% increase from 1st January 2024 to 21 Nov 2024. Our analysis of Pfizer for 2025 predicts an additional rise of 28.45% to 32.2% by the end of 2025 with three potential targets T1: 6591.54, T2: 6657.46, T3: 6783.95. Stop Loss at SL1: 4785.05, SL2: 4673.85, SL3: 4625.00.
Pfizer has a All-Time high of ₹6451.14, acting as a crucial resistance level - a ceiling that could challenge further price increase. Conversely, it has a 52-week low of ₹3950.00, a critical support level - think of this as a safety net where the price might stop falling.
After looking at 2024's and 2025's share price prediction, you might wonder what are short term targets for Pfizer, we have created a specific page for that check here: Pfizer Share Price Target For Tomorrow & Next Week
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Pfizer Long Term Share Price Prediction Chart From 2024, 2025, 2026 to 2039
This chart presents a detailed projection of Pfizer share price predictions from 2024, 2025, 2026 to 2039. This share price Prediction represents a CAGR of 11.22% over the next 15 years.
For complete year by year Pfizer long term share price target from 2024, 2025 to 2039 check the below table.
Pfizer Share Price Target Table From 2024, 2025, 2026 to 2039
| Year | Pfizer Target | YoY Change % |
|---|---|---|
| 2024 | ₹5,131.29 | [Current Price] |
| 2024 | ₹5,856.24 | 14.12% |
| 2025 | ₹7,093.02 | 21.11% |
| 2026 | ₹8,751.74 | 23.38% |
| 2027 | ₹9,833.42 | 12.35% |
| 2028 | ₹12,319.71 | 25.28% |
| 2029 | ₹12,842.08 | 4.24% |
| 2030 | ₹13,924.4 | 8.42% |
| 2031 | ₹15,819.28 | 13.6% |
| 2032 | ₹16,670.25 | 5.37% |
| 2033 | ₹19,839.52 | 19.01% |
| 2034 | ₹19,827.91 | -0.06% |
| 2035 | ₹20,755.78 | 4.67% |
| 2036 | ₹22,886.82 | 10.26% |
| 2037 | ₹23,507.08 | 2.71% |
| 2038 | ₹27,359.33 | 16.38% |
| 2039 | ₹25,937.48 | -5.2% |
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Pfizer Past Performance
- In 2002, Pfizer opening price was ₹469.95
- As of Thu 21 Nov 2024 the price stands at ₹5,131.29.
- This represents a Compound Annual Growth Rate (CAGR) of 10.95%.
- In 22 years, an investment of 10,000 would have become ₹1.09 Lakh.
As we wrap up, we hope you like our study on Pfizer share price predictions, please kindly note that these forecasts are based on technical analysis, past trends, and machine learning models. They are for educational purposes only, not investment advice.
Show Methodology We Use
Methodology Behind the Prediction
The share price predictions present on our site are derived from a robust model that incorporates multiple economic indicators, technical indicators, company performance metrics, and industry-specific factors.
We have historical share price data of all stocks for which we present targets, so we analyse historical trends from those past data and overlay them with projected market conditions to estimate future share prices of a stock.
Disclaimer: Information is provided 'as is' and solely for informational and educational purposes, not for trading purposes or advice. We highly recommend to do your own research before making any investment.
